First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics
Sho Saito(National Center for Global Health and Medicine), Norio Ohmagari(National Center for Global Health and Medicine)
Cited by 197
Related Papers
Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed
|Archive ouverte UNIGE (University of Geneva)|2022|221
Autochthonous Dengue Fever, Tokyo, Japan, 2014
|Emerging infectious diseases|2014|137
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2
|Research Square|2022|41
Multi-year analysis of the global preclinical antibacterial pipeline: trends and gaps
|Antimicrobial Agents and Chemotherapy|2024|25